Share
clock Created with Sketch.
25/06/03
11:50
Share
M, I originally estimated the value of NV07-a at about $3.30 per share at Announcement for commercialisation. However, much depends on the destination of the product: 3.6 Is it a Cosmetic, a drug or both? http://www.cfsan.fda.gov/~dms/cos-218.html It seems to me that it is possible that the "drug" part could come later on as it may need another trial-Not too sure about that. Therefore ignore that $3.30 for the time being. Here is some reading: 13.2.1 Alohadan: NV07a - POTENTIAL ON STOCK PRICE http://www.ozestock.com.au/MessageView.asp?PostID=192212&Symbol=NRT 13.2 2 Big_One: http://www.ozestock.com.au/MessageView.asp?PostID=167546&Symbol=NRT 13.2.3: Big_One: NV07a: MARKETING AND POSSIBLE PARTNERS- three posts: http://www.ozestock.com.au/MessageView.asp?PostID=185341&Symbol=NRT http://www.ozestock.com.au/MessageView.asp?Symbol=NRT&PostID=185344 http://www.ozestock.com.au/MessageView.asp?Symbol=NRT&PostID=185345 13.3 Big_One: SALIENT ASPECTS OF NOVOGEN (AX.NRT)--Status Summary (3 posts): http://www.ozestock.com.au/MessageView.asp?PostID=169878&Symbol=NRT http://www.ozestock.com.au/MessageView.asp?Symbol=NRT&PostID=169879 (Please note the above mentioned Disclaimer; mentioned values cannot be guaranteed but are the opinion of the writer): http://www.ozestock.com.au/MessageView.asp?Symbol=NRT&PostID=169880 There is a considerable value here I believe, once the Announcement arrives, we may have another look again. Thanks for your question, Gerry